ARCHIVES

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NCAB Delays Decision On Organ Site Program Until May Meeting

February 12, 1982

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

Project Enlists PC Users In Quest For Cancer Drugs.

April 6, 2001

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998

NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies.

October 31, 2008